Cheil Bio Co Eulerpool News

Cheil Bio Co Stock News

Cheil Bio Co is being monitored by journalists and investors worldwide. We gather the latest Cheil Bio Co news here.

Cheil Bio Co Stock Press Releases

Cheil Bio Co regularly publishes news on the company's website that are relevant for investors.

Cheil Bio Co News 2026

This page contains all current news, analysis and press releases for Cheil Bio Co stock (052670.KQ, ISIN: KR7052670007). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Cheil Bio Co.

Cheil Bio Co Stock

Cheil Bio Co Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers.